A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Pain

Interventions

DRUG

Paracetamol 500 mg

Standard Paracetamol formulation

DRUG

Paracetamol 1000 mg

Paracetamol Sustained Release formulation

DRUG

Paracetamol 750 mg

Paracetamol Sustained Release formulation

Trial Locations (1)

Charles River Clinical Services Northwest, Inc., Tacoma